Partnership will drive cost savings for
customers while providing high-touch services that improve health
outcomes to members with chronic kidney disease
(CKD).
SEATTLE, Oct. 15,
2024 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD)
today announced that Renalogic, the recognized industry leader that
manages the human and financial costs of chronic kidney disease
(CKD) for self-insured employers and their members, will join the
company's Trusted Partner Ecosystem, to offer its proven CKD risk
management and dialysis cost containment solutions.
Employers' health costs are expected to rise, with the average
cost for employer sponsored care reaching $16,000 per employee in 2025, according to a
recent report from Aon. A small portion of any employee population
is affected by late-stage chronic kidney disease (CKD), but that
population drives disproportionately high costs for employers due
to the significant expenses associated with dialysis, especially
for those who begin dialysis unexpectedly in an acute setting.
Medicare often assumes responsibility for in-center dialysis costs
from commercial payers after 33 months, but Renalogic helps
employers control costs during that initial period while also
improving outcomes.
Renalogic helps self-insured health plans combat high dialysis
costs and improve health outcomes in several ways:
- Through ImpactIQ, Renalogic leverages its proprietary data
algorithms to stratify members who are both diagnosed and
undiagnosed with CKD, which gives insight into future high-cost
claims and a path to tailored interventions. Renalogic's data
algorithms are actuarially proven to be more than two times better
at identifying undiagnosed CKD than the traditional
marketplace.
- These identified members can benefit from ImpactAdvocate
to forestall end-stage renal disease (ESRD) and properly manage
dialysis starts when necessary. ImpactAdvocate consistently reduces
emergent starts by 30-50%, a critical opportunity to improve
survival rates and save as much as $50,000 per emergent start. Additionally,
Renalogic clients see their health plan members elect home dialysis
services at two times the national average, the result of the
education and support of ImpactAdvocate services.
- Through ImpactProtect, Renalogic advises plans regarding
fair market rates for dialysis services, leveraging proprietary
methodologies that can save employers 50-80% against contracted
rates on dialysis claims costs, which often equates to net savings
of $75,000 - $125,000 per member on dialysis per
year.
"We are excited to welcome Renalogic to Accolade's Trusted
Partner Ecosystem as our first partner solution dedicated to CKD,"
said Dr. Connie Hwang, Accolade's
Chief Clinical Officer. "Late-stage CKD is a complex and
challenging condition that significantly impacts our members'
quality of life. By integrating Renalogic's specialized clinical
and administrative services, we will empower our members to better
manage this complicated disease and ensure they receive the
tailored care and support they need through every stage of their
journey."
"We are thrilled to join forces with Accolade to bring our
expertise and proven methodology to their valued customers," said
Kevin Weinstein, Renalogic's CEO.
"With the incidence of late-stage CKD accelerating and dialysis
costs averaging $250,000 per member
per year, we are excited to empower Accolade's customers to
navigate and lower these overwhelming costs. Together, we are
committed to delivering significant value and improving outcomes
for those managing CKD."
Accolade and Renalogic will provide integrations to joint
customers to promote awareness of Renalogic's services at no
incremental cost, which includes warm handoffs from Accolade Care
Advocates to Renalogic's clinical team.
Representatives from Accolade and Renalogic will participate in
an upcoming webinar to discuss the new partnership.
Accolade's Trusted Partner Ecosystem
Launched in 2019, Accolade's Trusted Partner
Ecosystem accelerates the performance of digital health
solutions to improve outcomes across valued categories for
employers. Accolade's ecosystem currently consists of 18 partners
across 12 categories.
Benefits teams can confidently select from thoroughly vetted
solutions and enjoy streamlined contracting and implementation.
Through qualified referrals, Accolade drives more engagement with
partner solutions, leading to exponentially better health outcomes
and better value. Learn more here.
About Accolade
Accolade (Nasdaq: ACCD) is a Personalized
Healthcare company that provides millions of people and their
families with exceptional healthcare experiences so they can live
their healthiest lives. Accolade's employer, health plan, and
consumer solutions combine virtual primary care and mental health,
expert medical opinions, and best-in-class care navigation. These
offerings are built on a platform engineered to care through
predictive engagement of population health needs, proactive care
that improves outcomes and cost savings, and by addressing barriers
to access and continuity of care. Accolade consistently receives
consumer satisfaction ratings of over 90%. For more information,
visit accolade.com. Follow us
on LinkedIn, X, Instagram, and Facebook.
About Renalogic
Founded in 2002, Renalogic helps self-funded plans and their
members manage the human and financial costs of chronic kidney
disease (CKD) and dialysis treatment. Renalogic helps plans manage
dialysis claims with cost-containment and care management solutions
while working to prevent members from progressing to dialysis with
our advocacy and clinical care programs. These solutions and
programs have helped Renalogic clients save hundreds of millions of
dollars and helped stop CKD from progressing for thousands of
members. For more information, visit renalogic.com/. Follow us on
LinkedIn and Facebook.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/accolade-welcomes-renalogic-to-trusted-partner-ecosystem-302276201.html
SOURCE Accolade, Inc.